George Lloyd Miller

George Lloyd Miller discloses dealings in 2 companies, chiefly Sigma Aldrich Corp and West Pharmaceutical Services Inc. Over a trading history stretching from 30 September 2009 to 6 November 2020, the count stands at 67 filings.

On the open market, the record shows 3 purchases worth €115k and 5 sales worth €3.6M. Netting one side against the other leaves €3.5M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 35 share grants and 21 option exercises. In 2020 alone, the filings show no purchases and 3 sales.

A typical purchase (the median) is worth €54k.

The newest entry dates from 9 November 2020: an option exercise of €474k, in West Pharmaceutical Services Inc. The last insider purchase was made public on 29 August 2013, 4,819 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.